A CVC Capital Partners-led consortium is buying a controlling stake in pharmaceutical company Alvogen from private equity firm Pamplona Capital Management.
Alvogen, headquartered in Pine Brook, New Jersey, develops and manufactures generic, branded, over-the-counter and other products. The company is led by CEO Robert Wessman (pictured, left). The business operates in 35 regions, including: South Korea, West Balkan, Poland, Romania, Bulgaria, Hungary, Taiwan, Thailand, Ukraine, Russia, Japan and China. Terms of the transaction were not disclosed.